CSPC PHARMACEUTICAL GROUP LIMIT (CSPCY) Financials
CSPCY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | ? | ? |
| 2023-06-30 | 6.0 billion | 1.4 billion |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 6.1 billion | 1.5 billion |
CSPCY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | ? | ? |
| 2023-06-30 | 8.3 million | ? |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 29.7 million | ? |
CSPCY Net Income
| Date | Net Income |
|---|---|
| 2023-09-30 | 209.4 million |
| 2023-06-30 | 59.1 million |
| 2023-03-31 | 208.3 million |
| 2022-12-31 | 65.0 million |
CSPCY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | - | - | - |
| 2023-06-30 | 1.7 billion | - | 46.9 million |
| 2023-03-31 | - | - | - |
| 2022-12-31 | 2.0 billion | - | 58.1 million |
CSPCY Shares Outstanding
CSPCY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 188.4 million | 43.9 million | 291.9 million |
| 2023-06-30 | 20.4 million | 178.9 million | 37.6 million | 333.3 million |
| 2023-03-31 | - | 146.9 million | 38.3 million | 362.6 million |
| 2022-12-31 | 34.9 million | 154.8 million | 43.4 million | 322.7 million |
CSPCY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 1.1 billion | 305.8 million |
| 2023-06-30 | 1.1 billion | 318.6 million |
| 2023-03-31 | 1.2 billion | 369.4 million |
| 2022-12-31 | 1.1 billion | 329.1 million |
CSPCY
Price: $3.38
Dividend Yield: 0.07%
Forward Dividend Yield: 4.24%
Payout Ratio: 53.02%
Dividend Per Share: 0.14 USD
Earnings Per Share: 0.27 USD
P/E Ratio: 10.10
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 10.3 billion
Average Dividend Frequency: 2
Years Paying Dividends: 6
DGR3: 26.19%